For laboratory and educational research use only. Not medical advice.
Women's Peptide Research
Ask Vera
Home  /  Database  /  KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500
Skin & Hair

KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500

Skin & Hair · CAS GHK-Cu: 49557-75-7; KPV: 67727-97-3; BPC-157: 137525-51-0; TB500: 77591-33-4
Category
Skin & Hair
Evidence grade
Pending
PubMed records
Female-tagged
Sex-analysis
CAS
GHK-Cu: 49557-75-7; KPV: 67727-97-3; BPC-157: 137525-51-0; TB500: 77591-33-4
Multi-ingredient blend

This is a combination product, not a single compound, so it carries no evidence grade or female-evidence block of its own. Female evidence is reviewed per ingredient, follow the linked profiles below. We don't combine or invent evidence for blends.

Overview

The KLOW blend is a research blend that combines four peptides, GHK-Cu, KPV, BPC-157, and TB-500 (thymosin beta-4), supplied together in a single lyophilized vial for multi-pathway investigation. Blends of this kind let researchers study several signaling systems in parallel from one research material rather than reconstituting each component separately.

Each component contributes its own studied pathway. GHK-Cu, a copper-tripeptide complex, has been studied for collagen and extracellular-matrix signaling; KPV, the C-terminal tripeptide of alpha-MSH, has been investigated for anti-inflammatory and melanocortin-related pathways; BPC-157 has been characterized against angiogenic and cytoprotective mechanisms; and TB-500 has been studied for actin regulation and cell migration. Researchers examining tissue and matrix biology have used the combination as a single research material for probing these mechanisms together.

What makes the KLOW blend a notable entry for a skin and hair research catalog is the breadth of pathways represented in one preparation. Whether these mechanisms translate to female physiology remains an open research question; our evidence review tracks how many of the underlying studies included women. Supplied for in-vitro and laboratory research only.

Summary

The KLOW Blend combines four research peptides, GHK-Cu, KPV, BPC-157, and TB-500 (thymosin beta-4), in a single lyophilized vial for multi-pathway investigation. GHK-Cu is studied for collagen and matrix signaling; KPV (the C-terminal tripeptide of alpha-MSH) for anti-inflammatory and melanocortin-related pathways;…

Frequently asked questions

Answers drawn only from KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500's research facts and, where reviewed, its sex-disaggregated evidence. Nothing here is medical advice, dosing, or a claim of safety or efficacy.

What is KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500?

KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 is a multi-ingredient blend, not a single compound, so it carries no evidence grade of its own. The KLOW Blend combines four research peptides, GHK-Cu, KPV, BPC-157, and TB-500 (thymosin beta-4), in a single lyophilized vial for multi-pathway investigation.

What is in KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500?

KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 combines peptide ingredients (ghk cu, kpv, bpc 157, thymosin beta 4 tb500).

Is KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 studied in women?

We don't combine or invent evidence for blends. Female evidence is reviewed per ingredient, follow each ingredient's profile: ghk cu, kpv, bpc 157, thymosin beta 4 tb500. We never merge separate studies into a claim about the combination.

Does KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 have an evidence grade?

No. As a combination product, KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 is intentionally ungraded. Each constituent is graded on its own profile using the same derived method.

How should KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 be stored and handled?

KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 sold for research is supplied as a lyophilized (freeze-dried) powder. Lyophilized peptides are generally kept cold and dry, at roughly -20°C for longer-term storage and 2-8°C short-term, protected from light. Once reconstituted they are typically refrigerated and used within a short window, avoiding repeated freeze-thaw cycles. This is general laboratory handling for research use only, not a directive for human use. Always follow the handling and purity details on the product's Certificate of Analysis.

Where can I buy KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 for research?

For laboratory research use, KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 is available from our research-use partner, Aurevena Research. Applying code research15 takes 15% off. We may earn a commission when you purchase through this link, at no extra cost to you. Products are for laboratory research use only.

Buy KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 at Aurevena Research
Research-use supplier: KLOW - GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 is available from our research-use vendor for laboratory use. Code research15 for 15% off, applied automatically at checkout. We may earn a commission when you purchase through this link, at no extra cost to you. Products are for laboratory research use only.
Buy now →

Related peptides

Educational information for laboratory and research use only. Not medical advice, a recommendation, or a claim of safety or efficacy; no personal dosing. “Unstudied” means no qualifying study was found, not that a compound is safe or unsafe.